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Drawing on empirical research conducted in Argentina through the ESRC-funded ‘GET: Social Values Project’ (see 
http://www.law.ed.ac.uk/ahrc/esrcvaluesproject/), this Policy Brief (1) highlights the importance of moral foundations to science 
and regulation, (2) provides evidence of Argentine stakeholder views on the appropriate source of moral values for science 
boundary-setting, (3) provides evidence of Argentine stakeholder views on the values most important to the governance of stem cell 
and regenerative medicine research, and (4) offers recommendations on how to incorporate this evidence into bioscience and health 
research policy options in Argentina. 
THE IMPORTANCE OF MORALITY 
 
It has long been the view that science is not value-free and that activities in the 
biomedical research setting ought to be solidly grounded on the essential values 
of mankind.1  Similarly, it is generally recognized that law (and regulation) must 
have some moral basis if it is to be persuasive and legitimate, particularly where 
the subject conduct has some potential to harm.2  Ultimately, moral values are 
important to the realization of both good science and good governance, 
particularly where human health and wellbeing is implicated, and there is ample 
justification for their formulation in ‘biolaw’, which, by necessity, concerns 
matters having a strong a moral element.3 However, values are often more 
assumed than explicit, and are often extremely opaque or hidden, and therefore 
invisible.  One objective of the GET: Social Values Project was to make visible 
and explicit some of the values that Argentine stakeholders feel should influence 
the biomedical research setting and the legal and regulatory solutions created to 
solve actor problems in this arena.4 Exposing such values can enhance position 
comprehension and mutual understanding, and therefore discussion around ideals 
and trajectories for science and its regulation.  It can lead to deeper 
understandings, and, when approached positively, increase the potential for 
consensus. 
 
SOURCES OF MORAL VALUES 
 
Respondents in the GET: Social Values Project were asked to identify important 
and/or valued sources or shapers/informers of moral values.5  Collectively, they 
felt that core moral values should be derived from conversations around the 
following sources: (which are not here ranked or listed hierarchically): 6 
 
• the Hippocratic Oath; 
• moral theory based on rationality and common sense; 
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"[Moral 
values should 
come] from 
ethics theory, 
not from 
religion.  And 
not 
from 
ambiguous 
slogans, like 
'human 
dignity' or 
'sanctity' 
dogma." 
 
 
 
 
  
"The protection 
of human 
dignity.  And 
please notice 
that I don't say 
human 
lives, I say 
human dignity, 
because not 
always are 
[they] the same.  
But I 
would say that 
we have to 
speak a lot 
about human 
dignity.  People 
think it 
is very simple, 
but it is not.  It 
is a very difficult 
subject." 
• academic scholarship concerning justice and risk; 
• international human rights ideas; 
• spiritual writings (but not religious dogma). 
 
Such a ‘conversation’ was viewed as absolutely essential insofar as it would 
encourage a range of stakeholders to consider the consequences of actions, and 
therefore a range of options, before acting.   
 
Clearly, the idea of discussion and debate was felt to be important to uncovering, 
exploring and refining values.  Respondents specifically noted the social and 
dynamic nature of morality for which there could be no universal rule, and they 
felt that values must come from society; from informed people who are prepared 
to debate and to openly articulate moral values and defend the research 
boundaries they inform.  In short, social sources need to be consulted so as to 
generate good evidence and understanding.  Respondent 18 considered humans 
to be connected in a broad and loose way, so both individual judgments and 
communities are important in serving as a source of values.  Complementing 
this, several respondents cited the importance of education to the development 
of values and morality; education and the encouragement (and training) of 
rationality were viewed as important sources, and lack of education was seen as a 
danger to moral thinking. 
 
Despite a high level of agreement about the shared, social and evolutionary 
nature of values (and the morality which those values inform), respondents all 
acknowledged the importance of individual judgments.  Many respondents 
readily expressed scepticism toward religious institutions as a source, together 
with a strong doubt that such institutions could have any positive impact on the 
exercise of exploring moral values (or the development of rational biomedical 
research regulation).  Rather, they felt that moral values must come from outside 
the two (perceived) antagonists (ie: outside religious and science circles). 
 
MORAL VALUES FOR THE BIOSCIENCE SETTING 
 
Respondents in the GET: Social Values Project articulated a broad range values 
which they considered to be important not only to the bioscience and regulatory 
setting, but to Argentine society more generally.  The values which they felt were 
broadly important (for Argentina and beyond) were as follows: 
"I respect 
religion.  I am 
Catholic.  But I 
separate 
completely.  
And if 
there is a 
problem, I look 
from this, from 
this, from this 
[angle]. 
Factual." 
2  See H. Hart, Law, Liberty and Morality (Stanford: Stanford U Press, 1963), P. Devlin, The 
Enforcement of Morals (NY: OUP, 1968), R. Dworkin, Life’s Dominion (London: HarperCollins, 1993), 
and others. 
3  So argued in S. Harmon, “Control of Reproductive Treatment and Research: From the 
Moral to the Political to the Legal – and Back Again?” in C. Lyall, J. Smith & T. Papaioannou 
(eds.), The Limits of Governance: The Challenge of Policy-Making for the Life Sciences (Aldershot: Ashgate, 
2009) 79-104. 
4  For purposes of the GET: Social Values Project and this Policy Brief, the concept of 
‘values’ is interpreted as being deeply held ideas, beliefs or moral concepts which contribute to 
personal and social identity.  They are broader and more cross-contextually relevant (ie: more 
diffuse) than ‘principles’, which are viewed as lower level concepts more practically grounded, and 
more mechanistically directed. 
5  There were 22 respondents who participated in the GET: Social Values Project.  They 
were drawn from executive, legislative and regulatory bodies, the clinical and medical research 
communities, and the legal and ethical academic communities. 
6  The identification of these sources expose a blend of consequentialist and deontological 
approaches.  In the interviews, considered holistically, respondents were very concerned with 
consequences, although this did not always lead them to adopt strictly consequentialist approaches.  
Deontologically-sounding rules were also referenced or identified as being useful. 
 
 
 
 
  
 
"I love what you 
call the value of 
solidarity, I think 
it is important 
because it 
includes the 
importance of 
more emotional 
attachment to 
others. 
And I am 
absolutely 
convinced that 
that is an 
essential part of a 
moral 
being, to be 
emotionally 
attached to 
others, to be 
close to others in 
the 
community." 
 
 
• Dignity: This is a broad value which seeps into all others in some way.  It 
was felt that we must recover the notion of the importance of humanity 
and of respecting people and frailties and vulnerabilities and 
potentialities.  It requires a balancing of research with other values, 
always being careful not to instrumentalise people. 
 
• Human Wellbeing: Everything depends on human health.  It is important 
to protect life, health, and wellbeing.  The restrictions placed on the 
pursuit of improving human wellbeing should be minimal.  Wellbeing, as 
a value, was tied to the conception of public or population health, which 
relies on a greater connection being made between research and clinical 
use (ie: research actions must have some public or population utility).  
One respondent argued that Argentina cannot compete economically so 
it needs to use funds in wise ways to develop experience and translate 
research into clinical uses. 
 
• Solidarity: This value focuses on social contacts, interconnectedness, 
emotional ties to others, and the common good.  It reminds us of our 
obligations to take care of people and help those in a weaker position to 
have some possibilities and to live with freedom.  It makes ‘public ethics’ 
important, which means we should measure the value of actions by how 
well they avoid selfish ends and generate social benefit (ie: are directed at 
solving society’s problems). 
 
• Justice: This value embodies equality and equity.  It demands the 
protection of the rights and wellbeing of everyone, especially the weak or 
vulnerable, and the just sharing of benefits throughout society (ie: the 
benefits of research must be made available and optimised). 
 
• Democracy:  This is an encompassing value that implicates engagement, 
participation, contribution, and societal control.  As a moral concept, it 
encourages participation in boundary-setting and trajectory-determining 
(ie: good science needs more than invested scientists thinking about it).  
It also embodies open debate and idea-exchange.  Governance efforts 
must recognise that no one has the absolute truth, but it must at the 
same time provide limits.  Democracy also acknowledges plurality, which 
is a reality in Argentine society.  There must therefore be a minimum 
level of liberty to act independently so long as others are not injured.  
Finally, democracy encourages accessibility of the governance framework 
(ie: the regulatory environment should not be too complex or rigid). 
 
• Knowledge: Knowledge is a value in itself, and needs to be generated 
within moral bounds, but in doing so, it is appropriate to push 
boundaries.  As part of this, creativity is very important; innovation in 
ways of thinking and opening up new pathways for creative thought. 
 
• Autonomy:  This is based on free will, self-rule, and the creation of space 
for people to make decisions about themselves and for themselves.  
People must be allowed to act in accordance with their feelings and 
desires.  Thus, donors, subjects and patient must receive adequate 
information so they can weigh options and make an informed decision (to 
consent to certain courses or refuse certain courses), and it imposes on 
"I have very 
simple ways of 
defining 
morality.  For 
me, it would be 
sentences like, 
'Don't do to the 
others the things 
that you don't 
want to be 
done upon you,' 
and 'Defend the 
rights of the 
people in terms 
of equality 
and justice.'" 
 
 
 
 
 
  
others the responsibility to hold personal information in confidence and 
to protect the privacy of others.  It also grounded the idea that people 
should retain control of their body and their body parts and products. 
 
Respondents in the GET: Social Values Project also had strong (and largely 
overlapping and consistent) views about the values that must shape the medical 
research undertaking itself, including researcher and physician action.  Key values 
repeatedly identified were: 
 
• Honesty: Researchers and physicians must be honest with patients, about 
patients, with research data, and they must not promise to do one thing 
and then do another.  Researchers must avoid hyperbole and inflated 
claims.  
• Safety: Donors, subjects and patients must be protected from harmful 
actions.  They must not be put at undue risk, and they must not be sold 
treatments that are not proved (eg: protect patients and research 
subjects).  This value is closely allied to non-maleficence (do no harm) 
and beneficence (actively do good), and it encourages us to avoid 
unnecessary risks, manage acceptable risks, and improve the quality of 
life of people, and to do so by understanding that only ‘good science’ 
must be pursued. 
 
• Scientific Freedom: This is the idea that a society must recognise some 
minimum level of liberty to act (and conduct research) in accordance 
with your own feelings and values so long as others are not injured.  This 
is important in a plural society.  Researchers have a responsibility take 
opportunities and push boundaries, but in the understanding that they 
have responsibilities to society; they must rely on, and generate, good 
evidence (eg: scientific veracity), and they must abide by research and 
clinical standards. 
 
• Transparency/Trust: This value imposes on researchers the need to be 
open about what they are doing and what they hope to achieve.  Publics 
have the right to know the scope and purpose of research, research risks, 
benefits and expectations, researcher conflicts, and what is behind the 
research (ie: the source and provenance of tissue sources).  Research 
must be transparent, its governance must be transparent, researchers 
should be called upon to defend and/or explain their work, and they 
should be expected to record and make public their work.  All of this will 
promote public trust. 
 
CONCLUSIONS AND OBSERVATIONS 
 
Despite the (perhaps surprising) number and range of values exposed, there is 
very little that appears to be particularly ‘Argentinean’ or distinctive about these 
values.  In many ways, they reflect (and perhaps add to) the values claimed by 
emerging international biolaw to be ‘universal’.  This may be unsurprising given 
that (1) many of the respondents received at least some of their education abroad 
(particularly in the USA), (2) some of the respondents rely on (or frequently have 
reference to) foreign or international professional standards, and (3) some of the 
respondents are involved in international collaborations (often with American 
and European partners).  What may emerge as particularly ‘Argentinean’ is the 
way that these values are marshalled or deployed, and to what end.  This is 
obviously an area worthy of further study, and, in fact, is the basis of further 
"[T]he only way 
to find [cures] is 
to research, and 
that is very 
important 
and necessary.  
[T]he main 
value is health 
and to find 
solutions for 
many 
things." 
"[It] is very 
important to 
open the debate 
and to have 
opposite visions 
of 
the subject 
sitting at the 
same table and 
think that 
maybe both 
have rights; 
that not one has 
the truth and 
one has not - 
maybe both 
have the truth.  
You 
need to really 
conclude what is 
the best for the 
country and for 
the people 
of the country." 
"I love 
discussion and 
want to open up 
the ideas of the 
people." 
 
 
 
 
 
 
 
 
 
 
"If God made 
us, He gave us 
intelligence to 
research 
medicine and to 
improve 
our situation, 
and therefore it 
is important for 
researchers to 
have freedom 
to develop 
science." 
projects being developed by the PI, Co-I and other partners. 
 
The above value evidence does not support any specific recommendations on 
how to proceed in Argentina from a governance or a regulatory point of view.  
However, this evidence does support some important observations: 
 
• No General Rule: A general rule, particularly a general prohibition in 
science, even one morally grounded, was considered by most 
respondents to be inappropriate because in every situation you must have 
the ability to rank values (ie: absolutes are unhelpful).7  Policymakers 
should avoid imposing blanket prohibitions to scientific pursuits. 
 
• Ranking Values: Respondents considered the ranking of the above values 
to be a social enterprise which requires debate.  Such a debate (about 
values and bioscience) has not yet happened in Argentina.  Policymakers 
and practitioners should take steps to begin engaging with different 
publics on the issue of values considered important to Argentina and to 
scientific advancement in Argentina, and should probe publics about 
desired health, healthcare and health research futures. 
 
• Boundary-Setting: Respondents felt that limited and rational boundaries 
for scientific research were appropriate and could encourage both good 
science and public trust and support.  Policymakers and publics should 
collaborate to set boundaries for science research, focusing on the 
professional responsibilities in the field, and ensuring that limits set are 
rationally defensible with reference to these values. 
 
 
"Autonomy, free 
will and options.  
But again, I 
think that the 
primary 
concern should 
be considering 
[these] in light 
of the 
vulnerability of 
our 
citizens." 
 
 
This Policy Brief forms part of the programme of work of the 
“Governing Emerging Technologies: Social Values and Stem 
Cell Regulation in Argentina” project funded by the ESRC 
(Award No. RES-000-22-2678) and supported by 
AHRC/SCRIPT and InnoGen.   
For more on the GET: Social Values project, visit  
http://www.law.ed.ac.uk/ahrc/esrcvaluesproject/relatedproject 
7  One respondent argued that ethics considered in a vacuum is unhelpful.  
There must be a context – a problem – within which one must bring these values 
to bear. 
